The stock price performance over the year has been a mixed bag, resulting in a range of outlooks from optimistic to pessimistic depending on the observer. The index has shown a price loss of -30.85% this year. Over the last six months, there has been a stronger performance of -27.22%. The price of CTKB leaped by -18.94% during the last 30 days period. For the last 5-days stocks have improved 2.77%.
Cytek Biosciences Inc. (CTKB) has a current stock price of $7.06. During the previous trading session, the stock witnessed a notable rise, reaching a high of $7.4349 after opening at $7.33. The stock’s low for the day was $7.03, and it eventually closed at $7.26.
Top 5 EV Tech Stocks to Buy for 2023
The electric vehicle boom is accelerating – and fast. According a new report published by BloombergNEF, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now. Get our free report, "Top 5 EV Tech Stocks to Buy for 2023".
Click Here to Download the FREE Report.
Sponsored
Cytek Biosciences Inc.’s stock has seen a rocky market performance. The company’s stock achieved a 1-year high of $15.90 on 10/04/22, and the lowest price during that time was $6.45, recorded on 05/18/23.
52-week price history of CTKB Stock
A stock’s 52-week price history, including the low and high prices, can offer valuable insights into its current standing and future prospects. Cytek Biosciences Inc.’s current trading price is -55.60% away from its 52-week high, while its distance from the 52-week low is 9.46%. The stock’s price range over this timeframe has been between $6.45 and $15.90. The shares of the Healthcare sector company recorded a trading volume of approximately 1.17 million for the day, which was comparatively higher than the average daily volume of 0.81 million over the last three months.
The Connection Between Financial Performance and Market Capitalization
Cytek Biosciences Inc. (CTKB) has experienced a quarterly decline of -15.75% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 962.70M and boasts a workforce of 699 employees.
How Moving Averages and Trading Volume Data Work Together
Based on Barchart.com data, the company’s moving average over the 100-day period was 8.58, with a change in price of -3.04. Similarly, Cytek Biosciences Inc. recorded 1,193,638 in trading volume during the last 100 days, posting a change of -30.10%.
CTKB’s Debt-to-Equity Ratio: A Comprehensive Review
A key metric for assessing a company’s financial well-being and market status is the debt-to-equity (D/E) ratio. This ratio is derived by dividing a company’s total liabilities by its shareholders’ equity, and it demonstrates the level of debt a company uses to support its assets relative to shareholder equity. At the time of writing, the total D/E ratio for CTKB stands at 0.01. Similarly, the long-term debt-to-equity ratio is also 0.00.
CTKB Stock Stochastic Average
The raw stochastic average for Cytek Biosciences Inc. over the last 50 days is presently at 11.58%. This reflects a drop from the raw stochastic average of the previous 20 days, which was noted at 17.37%. Further, the company’s Stochastic %K and %D values for the last 20 days were 21.86% and 17.94%, respectively.
